Search results for "Heart failure"
March 16, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/03/16/
Sacubitril-valsartan appears cost-effective in certain heart failure patients
Cost per quality-adjusted life-year gained in sacubitril-valsartan patients was $44,531 in those with NYHA class II heart failure and $58,194 in those with NYHA class III or IV heart failure.
https://acphospitalist.acponline.org/weekly/archives/2016/08/31/4.htm
31 Aug 2016
Advanced dementia and respiratory failure
A case highlights the importance of addressing prognosis before making care decisions.
https://acphospitalist.acponline.org/archives/2024/01/31/free/advanced-dementia-and-respiratory-failure.htm
31 Jan 2024
AHA evaluates heart failure risks from prescription drugs, OTCs, alternative products
The new comprehensive guide identifies prescription medications that may exacerbate underlying myocardial dysfunction or are known to cause direct myocardial toxicity.
https://acphospitalist.acponline.org/weekly/archives/2016/07/20/2.htm
20 Jul 2016
IV iron reduces risk of death, hospitalization in heart failure, meta-analysis finds
The combined results of 14 trials testing IV iron in patients with iron deficiency and heart failures showed significant benefit from iron overall, with potentially greater effect in those with lower baseline transferrin saturation.
https://acphospitalist.acponline.org/archives/2024/01/03/iv-iron-reduces-risk-of-death-hospitalization-in-heart-failure-meta-analysis-finds.htm
3 Jan 2024
CHA2DS2-VASc modestly predicts ischemic stroke, thromboembolism, death in heart failure patients
The observation that the risk factors included in the score are particularly significant among heart failure patients without atrial fibrillation is an important result, study authors said.
https://acphospitalist.acponline.org/weekly/archives/2015/09/02/4.htm
2 Sep 2015
Early treatment with spironolactone not effective for new-onset acute HF
Patients with acute heart failure (HF) who received spironolactone at discharge did not have a lower risk for HF readmission or mortality over the next year but were at higher risk for hyperkalemia, a retrospective cohort study in U.S. hospitals found.
https://acphospitalist.acponline.org/archives/2024/03/06/early-treatment-with-spironolactone-not-effective-for-new-onset-acute-hf.htm
6 Mar 2024
Guideline updated to include new drugs for stage C heart failure with reduced ejection fraction
The update to the 2013 American College of Cardiology Foundation/American Heart Association guideline adds the angiotensin receptor-neprilysin inhibitor valsartan/sacubitril and the sinoatrial node modulator ivabradine to the list of treatment options.
https://acphospitalist.acponline.org/weekly/archives/2016/05/25/3.htm
25 May 2016
Urine sodium excretion associated with six-month mortality in hospitalized heart failure patients
A study measured 24-hour sodium excretion in patients receiving high-dose loop diuretic therapy for an acute heart failure decompensation and found that it was highly variable both within and among patients.
https://acphospitalist.acponline.org/weekly/archives/2019/05/01/1.htm
1 May 2019
August 2017
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2017/08/